期刊文献+

miR-503下调Bcl-2增强BEL-7402/5-FU细胞对5-氟尿嘧啶的敏感性 被引量:1

miRNA-195 sensitizes BEL-7402/5-FU cells to 5-fluorouracil via down-regulating Bcl-2 expression
下载PDF
导出
摘要 目的:探讨miR-503通过调控Bcl-2的表达介导肝癌耐药细胞株BEL-7402/5-FU对5-氟尿嘧啶敏感性的影响.方法:microRNA(miRNA)芯片筛选BEL-7402与BEL-7402/5-FU细胞中表达差异的miR-503为候选的miRNA;脂质体转染法将miR-503模拟物瞬时转染至BEL-7402/5-FU细胞;实时定量聚合酶链式反应(qRT-PCR)检测BEL-7402/5-FU及其亲本细胞中miR-503、Bcl-2 mRNA的表达水平;Western Blot观察肝癌细胞中Bcl-2蛋白的表达水平;CCK-8法检测细胞药物敏感性的改变.结果:相比于BEL-7402细胞,miR-503在BEL-7402/5-FU细胞中表达水平下调,而Bcl-2蛋白的表达水平上调;miR-503过表达后BEL-7402/5-FU细胞中的Bcl-2在mRNA和蛋白水平上表达降低;miR-503转染组的BEL-7402/5-FU细胞活力较miRNA阴性对照组显著降低.结论:miR-503可能通过下调Bcl-2的表达,进而增强BEL-7402/5-FU细胞对5-氟尿嘧啶的药物敏感性,抑制细胞增殖. Aim:This study is to investigate the effects of miR-503 on 5-fluorouracil sensitivity of liver cancer drug resistant cell lines BEL-7402/5-FU by down-regulating Bcl-2 expression. Methods: Differentially expressed miR-503 between BEL-402 and BEL-7402/5-FU cells was screened by microRNA( miRNA),and was to be a candidate miRNA. MiR-503 mimic matter was transient transfected to the BEL-7402/5-FU cells by liposome transfection method. MiR-503 and Bcl-2 mRNA expression level of BEL-7402/5-FU and its parental cells were measured by qRT-PCR. Bcl-2 protein level was detected by western blot. Cell viability of each group was measured by CCK-8 assay. Results: MiR-503 level was downregulated and Bcl-2 protein expression level was up-regulated in BEL-7402/5-FU cells compared with BEL-7402 cells. MiR-503 could significantly down-regulate Bcl-2 expression in BEL-7402/5-FU cells.BEL-7402/5-FU cell vitality of miR-503 transfection was significantly reduced compared with negative control. Conclusion:miR-503 could enhance sensitivity of BEL-7402/5-FU cells to 5-fluorouracil and in-hibited cells proliferation via down-regulating Bcl-2 expression.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2017年第1期25-29,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家自然科学基金项目(81372579) 湖南省卫生厅医药卫生资助科研项目(B2014-048)
关键词 MiR-503 BCL-2 BEL-7402/5-FU细胞 5-氟尿嘧啶 MiR-503 Bcl-2 BEL-7402/5-FU cells 5-fluorouracil
  • 相关文献

参考文献2

二级参考文献31

  • 1Lippert TH,Ruoff H J,Volm M. Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure. Arzneimittelforschung 2008; 58:261-264.
  • 2Fojo T. Multiple paths to a drug resistance phenotype:mutations,translocations,deletions and amplification of coding genes or promoter regions,epigenetic changes and microRNAs. Drug Resist Updat 2007; 10:59-67.
  • 3Sharma SV,Lee DY,Li B,Quinlan MP,Takahashi F,Maheswaran S,et al. A chromatin-mediated reversible drugtolerant state in cancer cell subpopulations. Cell 2010; 141:69-80.
  • 4Lee RC,Feinbaum RL,Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-854.
  • 5Hummel R,Hussey DJ,Haier J. MicroRNAs:predictors and modifiers of chemo-and radiotherapy in different tumour types. Eur J Cancer 2010; 46:298-311.
  • 6Lu YC,Chen YJ,Wang HM,Tsai CY,Chen WH,Huang YC,et al. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila) 2012; 5:665-674.
  • 7Zhou J,Wang W. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell. J Surg Onco12011; 104:278-283.
  • 8Corbetta S,Vaira V,Guamieri V,Scillitani A,Eller-Vainicher C,Ferrero S,et al. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer 2010; 17:135-146.
  • 9Zhao JJ,Yang J,Lin J,Yao N,Zhu Y,Zheng J,et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 2009; 25:13-20.
  • 10(O)zata DM,Caramuta S,Veláquez-Fernández D,Ak(c)akaya P,Xie H,H(oo)g A,et al. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer 2011; 18:643-655.

共引文献26

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部